NVS
$98.45
Revenue | $13172Mn |
Net Profits | $3189Mn |
Net Profit Margins | 24.21% |
Novartis Ag’s revenue jumped 8.93% since last year same period to $13172Mn in the Q3 2024. On a quarterly growth basis, Novartis Ag has generated 5.27% jump in its revenue since last 3-months.
Novartis Ag’s net profit jumped 81.09% since last year same period to $3189Mn in the Q3 2024. On a quarterly growth basis, Novartis Ag has generated -1.76% fall in its net profits since last 3-months.
Novartis Ag’s net profit margin jumped 66.24% since last year same period to 24.21% in the Q3 2024. On a quarterly growth basis, Novartis Ag has generated -6.68% fall in its net profit margins since last 3-months.
EPS Estimate Current Quarter | 1.96 |
EPS Estimate Current Year | 1.96 |
Novartis Ag’s earning per share (EPS) estimates for the current quarter stand at 1.96 - a 3.7% jump from last quarter’s estimates.
Novartis Ag’s earning per share (EPS) estimates for the current year stand at 1.96.
Earning Per Share (EPS) | 2.06 |
Novartis Ag’s earning per share (EPS) jumped 12.57% since last year same period to 2.06 in the Q3 2024. This indicates that the Novartis Ag has generated 12.57% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2024-09-30 | 1.96 | 2.06 | 5.1% |
2024-06-30 | 1.89 | 1.97 | 4.23% |
2024-03-31 | 1.69 | 1.8 | 6.51% |